- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
Borrowing from a Nobel Prize-winning technique credited with starting the nanotechnology revolution, a team of researchers from Oak Ridge National Laboratory (ORNL) and Northwestern University's Nanomaterials for Cancer Diagnostics and Therapeutics has developed a method for imaging nanoparticles inside of cells. This technique should prove useful for studies of nanomaterials toxicology as well as those designed to improve nanoparticle-based drug delivery. This work has been published online in advance of print publication in the journal Nature Nanotechnology.
Ali Passian, Ph.D., and his colleagues at ORNL teamed with a research group headed by Vinayak Dravid, Ph.D., at Northwestern to probe the fate of individual nanoparticles inside of cells. Dravid and colleague Gajendra Shekhawat, Ph.D., had earlier developed a modified form of scanning electron microscopy, the Nobel Prize-winning invention, that uses nanoscale cantilevers as ultrasonic probes that can create a holographic image of a rapidly vibrating soft object lying beneath the cantilever as it scans that object. This new form of nanometer-resolution microscopy is known as scanning near-field ultrasonic holography, or SNFUH, and Dravid's research group has used it to generate detailed three-dimensional maps of soft objects.
Making use of SNFUH, Passian and his collaborators examined various cells taken from mice a week after the animals had been exposed to aerosolized nanoparticles known as single-walled carbon nanohorns, which are closely related to carbon nanotubes. Images of lung macrophages clearly revealed the exact location of individual nanohorns within the cells. The researchers also imaged nanohorns present inside red blood cells taken from the bloodstream, demonstrating that the nanohorns escape the lung and enter the circulatory system.
About National Cancer Institute
To help meet the goal of reducing the burden of cancer, the National Cancer Institute (NCI), part of the National Institutes of Health, is engaged in efforts to harness the power of nanotechnology to radically change the way we diagnose, treat and prevent cancer.
The NCI Alliance for Nanotechnology in Cancer is a comprehensive, systematized initiative encompassing the public and private sectors, designed to accelerate the application of the best capabilities of nanotechnology to cancer.
Currently, scientists are limited in their ability to turn promising molecular discoveries into benefits for cancer patients. Nanotechnology can provide the technical power and tools that will enable those developing new diagnostics, therapeutics, and preventives to keep pace with today’s explosion in knowledge.
For more information, please click here
National Cancer Institute
Office of Technology & Industrial Relations
ATTN: NCI Alliance for Nanotechnology in Cancer
Building 31, Room 10A49
31 Center Drive , MSC 2580
Bethesda , MD 20892-2580
Copyright © National Cancer InstituteIf you have a comment, please Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
|Related News Press|
News and information
Stealth nanocapsules kill Chagas parasites in mouse models June 22nd, 2016